Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.41 |
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26677777 | 1.00 | PDK2 (0.53) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL30003384 | 0.92 | PDK2 (0.59) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL789268 | 0.92 | PDK2 (0.59) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL20941772 | 0.92 | PDK2 (0.59) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL31668465 | 0.92 | PDK2 (0.59) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL30511893 | 0.92 | PDK2 (0.59) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL21391631 | 0.92 | PDK2 (0.59) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL3415232 | 0.84 | ALOX5 (0.55) | PDK2ESR2ESR1ALOX5HPGD | |
| SCHEMBL4205297 | 0.82 | PDK2 (0.53) | PDK2ESR2ESR1PDE4DALOX5 | |
| SCHEMBL20218919 | 0.81 | PDK2 (0.53) | PDK2ESR2ESR1PDE4DALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296076-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | INV NYLON CHEMICALS AMERICAS, LLC | 2025-09-25 | — | — | US | disclosed |
| EP-4499303-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | INVISTA Textiles (U.K.) Limited (GB) | 2025-02-05 | — | — | EP | disclosed |
| CN-118891103-A | Multidentate phosphite ligands, catalytic compositions containing such ligands, and catalytic methods utilizing such catalytic compositions | 英威达纺织（英国）有限公司 | 2024-11-01 | — | — | CN | disclosed |
| WO-2023228077-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | INV NYLON CHEMICALS AMERICAS, LLC (US) | 2023-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296076-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | PHOSPHO1, PPA1, PNKP | PDK2 173/4885ESR2 3114/4885ESR1 1721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.